Tang JH - Search Results

1

Clinical comparison of safety and efficacy of vinorelbine/epirubicin (NE) with fluorouracil/epirubicin/cyclophosphamide (FEC).

Yan PW, Huang XE, Jiang Y, Tang JH, Xu HX, Xu X, Jin X. Yan PW, et al. Among authors: tang jh. Asian Pac J Cancer Prev. 2010;11(4):1115-8. Asian Pac J Cancer Prev. 2010. PMID: 21133634 Free article. Clinical Trial.

2

Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.

Huo X, Lu C, Huang X, Hu Z, Jin G, Ma H, Wang X, Qin J, Wang X, Shen H, Tang J. Huo X, et al. J Cancer Res Clin Oncol. 2009 Nov;135(11):1569-75. doi: 10.1007/s00432-009-0604-6. Epub 2009 May 31. J Cancer Res Clin Oncol. 2009. PMID: 19484476

3

Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.

Yao CY, Huang XE, Li C, Shen HB, Shi MQ, Feng JF, Pan LX, Tang JH. Yao CY, et al. Among authors: tang jh. Asian Pac J Cancer Prev. 2009;10(5):859-64. Asian Pac J Cancer Prev. 2009. PMID: 20104979 Free article.

4

Body size, physical activity and risk of breast cancer - a case control study in Jangsu Province of China.

Gao CM, Tajima K, Ding JH, Tang JH, Wu JZ, Li SP, Cao HX, Liu YT, Su P, Qian Y, Chang J, Takezaki T. Gao CM, et al. Among authors: tang jh. Asian Pac J Cancer Prev. 2009;10(5):877-81. Asian Pac J Cancer Prev. 2009. PMID: 20104981 Free article.

5

Circulating levels of angiogenic cytokines in advanced breast cancer patients with system chemotherapy and their potential value in monitoring disease course.

Tang JH, Zhao JH, Lu JW, Yan F, Qin JW, Xu B. Tang JH, et al. J Cancer Res Clin Oncol. 2011 Jan;137(1):55-63. doi: 10.1007/s00432-010-0859-y. Epub 2010 Mar 10. J Cancer Res Clin Oncol. 2011. PMID: 20221635

6

Clinical observations on safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion.

Yao CY, Huang XE, Tang JH, Xu HX. Yao CY, et al. Among authors: tang jh. Asian Pac J Cancer Prev. 2010;11(2):553-5. Asian Pac J Cancer Prev. 2010. PMID: 20843150 Free article.

7

Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy.

Jiang Y, Huang XE, Yan PW, Cui L, Tang JH, Xiang J. Jiang Y, et al. Among authors: tang jh. Asian Pac J Cancer Prev. 2010;11(4):1059-62. Asian Pac J Cancer Prev. 2010. PMID: 21133624 Free article.

8

A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial.

Gao LL, Huang XE, Zhang Q, Tang JH. Gao LL, et al. Among authors: tang jh. Asian Pac J Cancer Prev. 2011;12(1):77-80. Asian Pac J Cancer Prev. 2011. PMID: 21517235 Free article. Clinical Trial.

9

Physiological, reproductive factors and breast cancer risk in Jiangsu province of China.

Liu YT, Gao CM, Ding JH, Li SP, Cao HX, Wu JZ, Tang JH, Qian Y, Tajima K. Liu YT, et al. Among authors: tang jh. Asian Pac J Cancer Prev. 2011;12(3):787-90. Asian Pac J Cancer Prev. 2011. PMID: 21627384 Free article. Clinical Trial.

10

Clinical comparison on the safety and efficacy of fluorouracil/pirarubicin/cyclophosphamide (FPC) with fluorouracil/ epirubicin/cyclophosphamide (FEC) as postoperative adjuvant chemotherapy in breast cancer.

Li Y, Tang JH, Huang XE, Li CG. Li Y, et al. Among authors: tang jh. Asian Pac J Cancer Prev. 2011;12(7):1795-8. Asian Pac J Cancer Prev. 2011. PMID: 22126567 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

487 results

Search Page

Filters